Elliptic Labs – Exercise of options under share option program, share capital increase and mandatory notification of trade

Oslo, Norway — Elliptic Labs (OSE: ELABS): Following the exercise of share options by option holders under Elliptic Laboratories ASA's ("Elliptic Labs" or the "Company") share option program, the Company's board of directors has, based on the authorization granted by the general meeting on 22 May 2024, resolved to increase the Company's share capital by a total of NOK 4,369.98, by the issuance of in aggregate 436,998 new shares. 300,000 of the shares have a subscription price of NOK 10.00 per share, and 136,998 of the shares have a subscription price of NOK 13.396 per share.
 
Following registration of the share capital increases pertaining to the issuances of new shares, the share capital will be NOK 1,052,749.68, divided into 105,274,968 shares, each with a par value of NOK 0.01.
 
The primary insider Espen Klovning has exercised 300,000 options under the share option program at a price of NOK 10.00 per share and the primary insider Åslaug Tveiterås has exercised 33,333 options under the share option program at a price of NOK 13.396 per share. See the attached forms for further details about the transactions.
 
All the exercised options have been granted in accordance with the Company's share option program described in the Company's latest annual financial statements.